CXCL8 and renal cell carcinoma: Moreover, IL1-stimulated RCC cells expressed higher levels of CXCL8 (IL-8) that was previously associated with lack of response to immune checkpoint inhibitors (60), further reinforcing the pro-tumoral role of IL1 not only on the immune microenvironment but also acting directly on epithelial malignant cells.